Faruqi & Faruqi Investigates Potential Claims Against Lufax
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy LU?
Source: PRnewswire
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Faruqi & Faruqi Investigates Potential Claims Against Lufax
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
See More
Lufax Securities Fraud Class Action Reminder
- Class Action Notice: Lufax (NYSE: LU) investors are reminded of an upcoming securities fraud class action lawsuit concerning shares purchased between April 7, 2023, and January 26, 2025, urging those who suffered losses during this period to take note of the impending legal action.
- Lawsuit Details: Filed in the U.S. District Court for the Central District of California, the lawsuit alleges that Lufax and certain senior officers violated the Securities Exchange Act of 1934, claiming that misrepresentations regarding the company's internal controls led to materially misstated financial results, potentially impacting investor recovery rights.
- Lead Plaintiff Requirements: Investors wishing to serve as lead plaintiffs must file necessary documents by May 20, 2026, with the lead plaintiff representing other class members in directing the litigation, while those opting not to participate can still share in any potential recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to take action.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, emphasizing the urgency for investors to file lead plaintiff motions by the specified deadlines.
- Gemini Lawsuit Details: The lawsuit against Gemini alleges that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to a significant overestimation of its post-IPO financial prospects and exposing it to potential costly and disruptive restructuring risks.
- Power Solutions Allegations: Power Solutions is accused in a lawsuit covering May 2025 to March 2026 of overstating its ability to capture sales demand in the data center market and failing to adequately disclose the costs and inefficiencies related to manufacturing capacity enhancements, resulting in materially misleading positive statements.
- Hercules and Lufax Issues: Hercules Capital is alleged to have overstated its due diligence processes from May 2025 to February 2026, while Lufax faces legal challenges due to inadequate internal controls and materially misstated financial results, highlighting serious deficiencies in transparency and compliance within these companies.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. faces a class action for the period from April 7, 2023, to January 26, 2025, due to undisclosed internal control deficiencies and misstated financial results, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotechnology Issues: Atara Biotherapeutics, Inc. is involved in a class action for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, likely to have a significant negative impact on the company's financial condition.
- Coty Performance Decline: Coty Inc. is facing a class action for the period from November 5, 2025, to February 4, 2026, due to undisclosed underperformance in its Consumer Beauty segment and slowing market growth, with a lead plaintiff deadline of May 22, 2026, which may affect the company's future market performance.
- Legal Consultation Opportunity: Investors are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights and explore participation in these class actions, indicating that the legal risks faced by these companies could impact shareholder confidence and market performance.
See More
Lufax Faces Securities Class Action Lawsuit
- Lawsuit Background: Lufax (NYSE: LU) is facing a securities class action lawsuit for undisclosed related-party transactions, representing investors from April 7, 2023, to January 26, 2025, highlighting significant deficiencies in the company's transparency and compliance.
- Auditor Change Impact: On January 27, 2025, Lufax announced the removal of PricewaterhouseCoopers as its auditor, resulting in a nearly 14% drop in share price that day, reflecting market concerns over the company's financial transparency.
- Internal Control Deficiencies: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated its financial results, potentially leading investors to misjudge the company's financial health, thereby affecting future investment decisions.
- Investigation and Consequences: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, and if proven, this could lead to broader legal liabilities and long-term damage to the company's reputation.
See More
Lufax Faces Class Action Lawsuit, Investors at Risk
- Lawsuit Announcement: Berger Montague PC has initiated a class action lawsuit against Lufax on behalf of investors who acquired Lufax American Depositary Shares between April 7, 2023, and January 26, 2025, alleging misrepresentation of financial results and inadequate internal controls during this period.
- Auditor Replacement: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns raised about the company's financial disclosures, particularly regarding related-party transactions, indicating a serious lack of financial transparency.
- Stock Price Reaction: Following the announcement of the auditor change, Lufax's ADS price fell by $0.40, a decline of over 13%, closing at $2.49 per ADS, reflecting increasing market concerns regarding the company's financial health.
- Investor Action Required: Investors must seek to be appointed as lead plaintiff representatives by May 20, 2026, to protect their rights, indicating that this lawsuit could have profound implications for Lufax's future operations and shareholder confidence.
See More
Faruqi & Faruqi Investigates Potential Claims Against Lufax
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
See More
Lufax Securities Fraud Class Action Reminder
- Class Action Notice: Lufax (NYSE: LU) investors are reminded of an upcoming securities fraud class action lawsuit concerning shares purchased between April 7, 2023, and January 26, 2025, urging those who suffered losses during this period to take note of the impending legal action.
- Lawsuit Details: Filed in the U.S. District Court for the Central District of California, the lawsuit alleges that Lufax and certain senior officers violated the Securities Exchange Act of 1934, claiming that misrepresentations regarding the company's internal controls led to materially misstated financial results, potentially impacting investor recovery rights.
- Lead Plaintiff Requirements: Investors wishing to serve as lead plaintiffs must file necessary documents by May 20, 2026, with the lead plaintiff representing other class members in directing the litigation, while those opting not to participate can still share in any potential recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to take action.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, emphasizing the urgency for investors to file lead plaintiff motions by the specified deadlines.
- Gemini Lawsuit Details: The lawsuit against Gemini alleges that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to a significant overestimation of its post-IPO financial prospects and exposing it to potential costly and disruptive restructuring risks.
- Power Solutions Allegations: Power Solutions is accused in a lawsuit covering May 2025 to March 2026 of overstating its ability to capture sales demand in the data center market and failing to adequately disclose the costs and inefficiencies related to manufacturing capacity enhancements, resulting in materially misleading positive statements.
- Hercules and Lufax Issues: Hercules Capital is alleged to have overstated its due diligence processes from May 2025 to February 2026, while Lufax faces legal challenges due to inadequate internal controls and materially misstated financial results, highlighting serious deficiencies in transparency and compliance within these companies.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. faces a class action for the period from April 7, 2023, to January 26, 2025, due to undisclosed internal control deficiencies and misstated financial results, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotechnology Issues: Atara Biotherapeutics, Inc. is involved in a class action for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, likely to have a significant negative impact on the company's financial condition.
- Coty Performance Decline: Coty Inc. is facing a class action for the period from November 5, 2025, to February 4, 2026, due to undisclosed underperformance in its Consumer Beauty segment and slowing market growth, with a lead plaintiff deadline of May 22, 2026, which may affect the company's future market performance.
- Legal Consultation Opportunity: Investors are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights and explore participation in these class actions, indicating that the legal risks faced by these companies could impact shareholder confidence and market performance.
See More
Lufax Faces Securities Class Action Lawsuit
- Lawsuit Background: Lufax (NYSE: LU) is facing a securities class action lawsuit for undisclosed related-party transactions, representing investors from April 7, 2023, to January 26, 2025, highlighting significant deficiencies in the company's transparency and compliance.
- Auditor Change Impact: On January 27, 2025, Lufax announced the removal of PricewaterhouseCoopers as its auditor, resulting in a nearly 14% drop in share price that day, reflecting market concerns over the company's financial transparency.
- Internal Control Deficiencies: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated its financial results, potentially leading investors to misjudge the company's financial health, thereby affecting future investment decisions.
- Investigation and Consequences: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, and if proven, this could lead to broader legal liabilities and long-term damage to the company's reputation.
See More
Lufax Faces Class Action Lawsuit, Investors at Risk
- Lawsuit Announcement: Berger Montague PC has initiated a class action lawsuit against Lufax on behalf of investors who acquired Lufax American Depositary Shares between April 7, 2023, and January 26, 2025, alleging misrepresentation of financial results and inadequate internal controls during this period.
- Auditor Replacement: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns raised about the company's financial disclosures, particularly regarding related-party transactions, indicating a serious lack of financial transparency.
- Stock Price Reaction: Following the announcement of the auditor change, Lufax's ADS price fell by $0.40, a decline of over 13%, closing at $2.49 per ADS, reflecting increasing market concerns regarding the company's financial health.
- Investor Action Required: Investors must seek to be appointed as lead plaintiff representatives by May 20, 2026, to protect their rights, indicating that this lawsuit could have profound implications for Lufax's future operations and shareholder confidence.
See More
